Cite
Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia.
MLA
Roch, Catherine, et al. “Nonclinical Pharmacology of Daridorexant: A New Dual Orexin Receptor Antagonist for the Treatment of Insomnia.” Psychopharmacology, vol. 238, no. 10, Oct. 2021, pp. 2693–708. EBSCOhost, https://doi.org/10.1007/s00213-021-05954-0.
APA
Roch, C., Bergamini, G., Steiner, M. A., & Clozel, M. (2021). Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia. Psychopharmacology, 238(10), 2693–2708. https://doi.org/10.1007/s00213-021-05954-0
Chicago
Roch, Catherine, Giorgio Bergamini, Michel A. Steiner, and Martine Clozel. 2021. “Nonclinical Pharmacology of Daridorexant: A New Dual Orexin Receptor Antagonist for the Treatment of Insomnia.” Psychopharmacology 238 (10): 2693–2708. doi:10.1007/s00213-021-05954-0.